Different effects of simvastatin on ex vivo monocyte cytokine release in patients with hypercholesterolemia and impaired glucose tolerance.

نویسندگان

  • R Krysiak
  • B Okopien
چکیده

The aim of our study was to compare the effect of simvastatin on systemic inflammation and monocyte secretory function between subjects with impaired glucose tolerance (IGT) and isolated hypercholesterolemia. We studied 26 patients with isolated IGT and 24 subjects with primary hypercholesterolemia, who were treated for 12 weeks with 20 mg of simvastatin daily. Plasma lipids, fasting and 2-h post-glucose load plasma glucose levels, HOMA ratio, glycated hemoglobin, plasma hsCRP levels and monocyte release of interleukin-6, interleukin-1β, MCP-1 and TNF-α were determined at entry, and after 4 and 12 weeks days of simvastatin administration. The control group included 25 age-, sex- and weight-matched dyslipidemia-free individuals with normal glucose tolerance. Compared to the control subjects, monocytes of both IGT and hypercholesterolemic subjects released greater amounts of interleukin-6, interleukin-1β, MCP-1 and TNF-α, and exhibited increased plasma hsCRP levels. No differences between IGT and hypercholesterolemic subjects in cytokine release and plasma hsCRP were observed. Despite improving lipid profile, simvastatin did not produce any effect on glucose metabolism markers in any treatment groups. In hypercholesterolemic subjects simvastatin reduced plasma hsCRP and monocyte cytokine secretion in a lipid- and glucose-independent manner, while in IGT subjects the drug produced only insignificant changes. Our results show that although low-grade systemic inflammation and monocyte secretory function are disturbed to a similar extent in isolated hypercholesterolemia and IGT, simvastatin exhibits a strong anti-inflammatory effect only in hypercholesterolemic patients.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes

OBJECTIVE To compare extra-lipid effects of statins and fibrates in relation to the baseline metabolic status of patients. RESEARCH DESIGN AND METHODS The study involved a group of 242 metabolic syndrome patients with or without pre-diabetes and randomized to atorvastatin, fenofibrate, or placebo. RESULTS Compared with matched healthy subjects, metabolic syndrome patients exhibited higher p...

متن کامل

Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients.

This study compared the effect of simvastatin on lymphocyte secretory function between patients with impaired glucose tolerance (IGT) (n=30) and mixed dyslipidemia (n=29). Lipid profile, glucose metabolism markers (fasting and 2-h post-glucose challenge glucose levels, HOMA-IR and glycated hemoglobin), plasma CRP levels and the release of interleukin-2 and interferon-γ by phytohemagglutinin-sti...

متن کامل

Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance.

BACKGROUND Fibrates were found to reduce cytokine release and low-grade inflammation in patients with impaired glucose tolerance. The aim of this study was to investigate whether these effects of fibrates may be potentiated by metformin treatment. METHODS The study included 43 patients with isolated impaired glucose tolerance and normal plasma lipids who had been treated for at least 6 months...

متن کامل

Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances.

The aim of this study was to compare the action of fenofibrate on monocyte cytokine release between patients with isolated mixed dyslipidemia and dyslipidemia coexisting with prediabetic states in relationship with its metabolic actions.We compared 96 primary mixed dyslipidemic patients and 29 age-, sex- and weight-matched control subjects with normal lipid profile. Depending on glucose metabol...

متن کامل

The relationship between pregnancy weight gain and impaired glucose tolerance test

Impaired glucose tolerance has several adverse effects on growing fetus. In this study we evaluated the effect of excessive weight gain during pregnancy on the risk of glucose intolerance in pregnant women. A case-control study was conducted through which the glucose tolerance status after 100 gram oral glucose intake was compared between 60 pregnant women with maximum 10 weeks of gestation and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

دوره 61 6  شماره 

صفحات  -

تاریخ انتشار 2010